Label (2nd Panel)
Drosera Pellet
Product Images NDC 0220-1785
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Drosera (NDC 0220-1785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (3rd Panel)
This is a description of a drug with the active ingredient listed as "s product name on front pane" containing 0.443 mg per pellet. The drug is intended for relief of symptoms, which can be found on the front panel. It is advised to stop using the drug if symptoms persist for more than 3 days or worsen. Women who are pregnant or breastfeeding should consult a healthcare professional before using it. The drug should be kept out of the reach of children. The recommended dosage is to dissolve 5 pellets under the tongue three times a day until symptoms are relieved or as directed by a doctor. It is not recommended to use the drug if the pellet dispenser seal is broken.*
Label (Drosera6c)
This is a description about a homeopathic medicine called Drosera. The medicine is available in a peel form and the lot number is not mentioned in the available text. The medicine is indicated for patients with a dry cough that gets worse at night and when exposed to heat. The text also mentions a HPUS NDC 0220-1785-41 number which may be a reference number for the medication. The text ends with an unreadable string of characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
